Primary CD30-Positive T-Cell Lymphoproliferative Disorder

Primary CD30-Positive T-Cell Lymphoproliferative Disorder — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01578499	A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)(ALCANZA)	completed	Phase 3	131	Millennium Pharmaceuticals, Inc.INDUSTRY	12	Jan 5, 2021	clinicaltrials

Data updated 22 days agoSource updated Jan 5, 2021source: clinicaltrials